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Background: Gremlin, a bone morphogenetic protein antagonist, plays an important role in the pathogenesis of
diabetic nephropathy (DN). However, the specific molecular mechanism underlying Gremlin’s involvement in DN
has not been fully elucidated. In the present study, we investigated the role of Gremlin on cell proliferation and
accumulation of extracellular matrix (ECM) in mouse mesangial cells (MMCs), and explored the relationship between
Gremlin and the ERK1/2 pathway.
Methods: To determine expression of Gremlin in MMCs after high glucose (HG) exposure, Gremlin mRNA and
protein expression were evaluated using real-time polymerase chain reaction and western blot analysis, respectively.
To determine the role of Gremlin on cell proliferation and accumulation of ECM, western blot analysis was used to
assess expression of pERK1/2, transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF).
Cell proliferation was examined by bromodeoxyuridine (BrdU) ELISA, and accumulation of collagen IV was
measured using a radioimmunoassay. This enabled the relationship between Gremlin and ERK1/2 pathway
activation to be investigated.
Results: HG exposure induced expression of Gremlin, which peaked 12 h after HG exposure. HG exposure alone or
transfection of normal-glucose (NG) exposed MMCs with Gremlin plasmid (NG + P) increased cell proliferation.
Transfection with Gremlin plasmid into MMCs previously exposed to HG (HG + P) significantly increased this HG-
induced phenomenon. HG and NG + P conditions up-regulated protein levels of TGF-β1, CTGF and collagen IV
accumulation, while HG + P significantly increased levels of these further. Inhibition of Gremlin with Gremlin siRNA
plasmid reversed the HG-induced phenomena. These data indicate that Gremlin can induce cell proliferation and
accumulation of ECM in MMCs. HG also induced the activation of the ERK1/2 pathway, which peaked 24 h after HG
exposure. HG and NG + P conditions induced overexpression of pERK1/2, whilst HG + P significantly induced levels
further. Inhibition of Gremlin by Gremlin siRNA plasmid reversed the HG-induced phenomena. This indicates
Gremlin can induce activation of the ERK1/2 pathway in MMCs.
Conclusion: Culture of MMCs in the presence of HG up-regulates expression of Gremlin. Gremlin induces cell
proliferation and accumulation of ECM in MMCs. and enhances activation of the ERK1/2 pathway.
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Gremlin is a 184-amino acid protein, which is a member of
the structural cysteine knot superfamily [1,2]. This protein is
evolutionarily conserved and the human Gremlin gene has
been mapped to chromosome 15q13-q15 [3,4]. Functionally,
Gremlin belongs to a novel family of BMP antagonists that
includes the head-inducing factor Cerberus and the tumor
suppressor DAN [5]. Under basal conditions, Gremlin is
present at relatively low levels in the adult kidney [6]. How-
ever, Gremlin is overexpressed in human mesangial cells
exposed to high extracellular glucose in vitro [7]. TGF-β,
when added to serum-restricted human mesangial cells, has
been found to augment Gremlin expression, but the stimu-
latory effect of high glucose on Gremlin expression can be
attenuated by the addition of anti-TGF-β antibody [7]. This
evidence indicates that Gremlin expression is induced by
TGF-β under diabetic conditions. These data suggest a
pathogenetic role for Gremlin in DN.
Gremlin gene expression is modulated by hyperglycemic
induction of the ERK1/2 in bovine retinal pericytes in re-
sponse to elevated glucose and in the retina of the strepto-
zotocin induced diabetic mouse [8]. ERK1/2 is a member
of the MAPK family [9]. The ERK1/2 pathway becomes
activated in mesangial cells cultured under high-glucose
conditions. This pathway and regulates many transcription
factors that control cell growth and ECM gene expression
[10]. In this way, it appears that the activation of ERK
pathway may be one of the major mechanisms involved in
high glucose-induced glomerular injury.
However, the molecular mechanism of Gremlin’s in-
volvement in DN has not been fully elucidated, espe-
cially the role of Gremlin on activation of the ERK1/2
pathway. For this reason, this study was designed to in-
vestigate the role of Gremlin on cell proliferation and ac-
cumulation of ECM in MMCs under HG conditions and
to explore the relationship between Gremlin and the
ERK1/2 pathway.
Methods
Cell line and reagents
MMCs were purchased from the American Type Culture
Collection (Manassas, VA, U.S.). Antibodies against TGF-
β1 was obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, U.S.). Antibodies against Gremlin and CTGF
were obtained from Abcam Biotechnology (Abcam, CA,
U.S.). Antiphosphotyrosine antibody for ERK1/2 and anti-
body for ERK1/2 were purchased from Cell Signaling
Technology (Beverly, MA, U.S.). The RT-PCR systems
were obtained from Takara Biotechnology (Dalian, China).
Construction of expression plasmids
The negative control plasmid (pEGFP-N1) and Gremlin
plasmid (pEGFP-N1-Grem1), were designed and produced
by Shanghai Yingweixin Co. The primer sequences foramplification of Grem1 gene are as follows: Grem1-F: 50-
ATGAATCGC ACCGCATACACTG-30, Grem1-R: 50-AT
CCAAGTCGATGGATATGCAA-30. The negative control
plasmid (pGenesil1.1) and Gremlin siRNA plasmid (pGene-
sil1.1-shGrem1) were designed and produced by Wuhan
Jingsai Co. The pGenesil1.1-shGrem1 was designed to
target the sequence 50-GCACATCCGAAAGGAGGAA-30.





Sense + Loop+Antisense + Endsignal + SalI +HindIII. To de-
termine the efficiency of the plasmids, MMCs cultured under
NG were transfected with these plasmids. Gremlin expression
was evaluated using western blot analysis and real-time poly-
merase chain reaction. The plasmids were all found to be ef-
fective and deemed suitable for the study.
Cell culture and transient transfection
MMCs were grown in DMEM-F12 (Gibco BRL) containing
10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin,
and 5% CO2:95% air at 37°C. Prior to use, cells at 80% con-
fluence were synchronized by culturing in serum-free
medium for 24 h. (1) To investigate the effects of glucose
on the expression of Gremlin and pERK1/2, MMCs were
stimulated with NG plus 24.5 mM mannitol (M) or HG for
0, 6, 12, 24 and 48 h. At the end of each time interval, total
RNA and protein of the cells were extracted for Gremlin
and pERK1/2 expression. All experiments were repeated
three times. (2) In order to determine the direct effects of
expression plasmids, the cells were transfected with 2.0 μg
of plasmid with 4 μl of Lipofectamine 2000 (Invitrogen,
CA, U.S.) in 2 ml of serum-free DMEM-F12 medium. At 6
h after transfection, the medium was replaced with normal
DMEM-F12 medium containing 10% fetal bovine serum
and cells were incubated for 24 h. Then the cells were cul-
tured for 24 h in DMEM-F12 containing HG or NG. At 24
h after HG stimulation, total RNA and protein were
extracted from the cells for analysis of Gremlin, TGF-β1,
CTGF, and pERK1/2 expression and culture medium was
collected for measurement of the concentration of collagen
IV. All experiments were repeated three times.
Real-time polymerase chain reaction (RT-PCR)
The cells were harvested and total RNA was extracted
using TriZol Reagent (Introvigen, Carlsbad, CA, U.S.)
according to the manufacturer’s instructions. RNA concen-
trations were determined using a Nanodrop ND-2000 spec-
trophotometer (Nanodrop Technologies, Wilmington, DE,
U.S.), and the complementary DNA (cDNA) was synthe-
sized from the total RNA (500 ng) using a PrimeScriptW
RT Reagent Kit (DRR037S, Takara Biotechnology, Dalian,
China) in accordance with the manufacturer’s instructions.
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SYBRW Premix Ex TaqTM (DRR041A, Takara Biotechnol-
ogy, Dalian, China). Each real-time PCR reaction consisted
of 2 μl of diluted RT product, 10 μl SYBRW Premix Ex
TaqTM and 200-nm specific primer pairs in a total volume
of 20 μl. The reactions were performed on a M× 3005P
real-time PCR System (Agilent Technologies) an initial 30 s
incubation at 95°C followed by 40 cycles (95°C for 5 s, 60°C
for 30 s 72°C for 20 s) after. The fold change in the mRNA
levels of each gene was calculated using the ΔΔCt method.
The housekeeping gene 18S rRNA served as an internal
control. All PCR primers were synthesized by Generay Bio-
tech, China. The primer sequences and the amplified
lengths used in the MMC study were as follows: Gremlin
(sense: 50-AGCAAAAGGGTTTTCCTGAT-30, antisense:
50-AATGGTCAGCATTTCACCCT-30, 200 bp), 18S rRNA
(sense: 50-ACA CGGACAGGATTGACAGA-30, antisense:
50-GGACATCTAAGGGCATCACAG- 30, 238 bp).
Western blotting
Total protein was extracted from cultured cells as
described previously [11]. The protein extracts were sepa-
rated using 10% SDS-PAGE and then transferred to PVDF
membranes. The membranes were incubated overnight
with rabbit polyclonal anti-Gremlin, ERK1/2, pERK1/2,
CTGF, β-actin (1:1000), and TGF-β1 (1:200) antibodies at
4°C. Then the membranes were incubated with horserad-
ish peroxidase-conjugated goat anti-rabbit IgG (1:5000)
and then exposed to X-ray film using an enhanced chemi-
luminescence system (Pierce, IL, U.S.). The intensity of
the bands was measured using LabWorks 4.5.
BrdU–Enzyme-linked Immunosorbent Assay (ELISA)
MMC proliferation was determined by measuring BrdU
incorporation using a BrdU incorporation assay (Roche
Molecular Biochemicals, Mannheim, Germany) according
to the manufacturer’s instructions. Briefly, 5,000 MMCs/
well seeded in a 96-well plate were pulse-labeled for 2 h
with 10 M BrdU. Cells were then incubated for 30 min
with diluted, peroxidase-conjugated anti-BrdU antibody.
Absorbance values were measured at 450 nm using an
ELISA reader (Bio-Rad iMark, Richmond, CA, USA).
Radioimmunoassay (RIA)
At the end of each time point, the supernatants from the
cell cultures were collected to measure collagen IV con-
tent. The concentration of collagen IV was determined
by radioimmunoassay (RIA) using commercially avail-
able kits (Beifang Inst. Biotechnology, Beijing, China)
according to the manufacturer’s instructions.
Statistical analysis
The data were normally distributed, as determined using
a Kolmogorov-Smirnov test. Comparisons among groupswere conducted using one-way ANOVA. When the F
value was significant (P < 0.05), the Student–Newman–
Keuls Test and least significant difference procedure
were performed to evaluate differences between the
means. All data were expressed as mean ± standard devi-
ation (SD) and analyzed using SPSS 18.0 for Windows.
Statistical significance was defined as P < 0.05.
Results
Effects of high glucose on the expression of Gremlin in
MMCs
In order to confirm the effects of glucose on the expres-
sion of Gremlin, MMCs were cultured in media contain-
ing 5.5 mM glucose (NG), then stimulated with NG plus
24.5 mM mannitol (M) or 30 mM glucose (HG) for 6,
12, 24, and 48 h. The expression of Gremlin mRNA was
detected using real-time polymerase chain reaction (RT-
PCR) analysis. We found that the level of Gremlin
mRNA increased within 6 h of HG stimulation (2.01 ±
0.20 fold, P < 0.01, vs NG) and peaked at 12 h (2.47 ±
0.23 fold, P < 0.01, vs NG) (Figure 1A). As shown in
Figure 1B, increased expression of Gremlin protein was
further confirmed by western blot. Consistent with the
results observed at the mRNA level, western blot ana-
lysis also showed a significant increase in Gremlin pro-
tein expression under high glucose conditions (30 mM)
at all time intervals. This increase peaked at 12 h (P <
0.01, vs NG). In addition, no differences were found in
MMCs cultured under conditions of NG plus mannitol
among different time points. These finding reveal that
Gremlin was involved in HG-induced effects in MMCs.
Transient transfection of MMCs with expression plasmids
Transient transfection of MMCs with Gremlin plasmid
(pEGFP-N1-Grem1) or Gremlin siRNA plasmid (pGene-
sil1.1-shGrem1) induced GFP expression, indicating suc-
cessful transfection. Increased expression of GFP was
detected 12 h after transfection and peaked at 48 h. At 48 h
after transfection, GFP expression was observed through the
comparative analysis of bright field images and correspond-
ing fluorescent images and about 60% (Gremlin plasmid)
and 65% (Gremlin siRNA plasmid) of the MMCs were
found to have been transfected successfully (Figure 2A, 2B).
To determine the efficiency of plasmids, Gremlin mRNA
and protein levels were assessed using RT-PCR and western
blot analysis at 48 h after transfection. Gremlin mRNA
was found to be markedly up-regulated to 1.60 ± 0.09 fold
(P < 0.01, vs NG) in Gremlin plasmid group (Figure 2C) and
inhibited to 0.27 ± 0.12 fold (P < 0.01, vs NG) in the Gremlin
siRNA plasmid group (Figure 2D). We also found that
transfection with Gremlin plasmid into MMCs significantly
increased the level of Gremlin protein (P < 0.01) over that of
the NG group (Figure 2E), and transfection with Gremlin
siRNA plasmid into MMCs significantly inhibited the level
Figure 1 Effects of HG on Gremlin protein and mRNA in MMCs over time. MMCs were cultured in media containing 5.5 mM glucose (NG),
then stimulated with NG plus 24.5 mM mannitol (M) or 30 mM glucose (HG) for 6, 12, 24, and 48 h. At the end of each time interval, total RNA
and protein of the cells were extracted for Gremlin mRNA and protein expression. (A) The level of Gremlin mRNA expression was detected using
real-time polymerase chain reaction (RT-PCR) analysis. (B) The expression of Gremlin protein was analyzed using western blot. Values are
expressed as means ± S.E.M. *P < 0.05, **P < 0.01 vs. NG.
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(Figure 2F). These findings reveal that the plasmids were all
effective and suitable for use in the study.
Effects of Gremlin on cell proliferation and ECM
accumulation in MMCs
The effects of Gremlin gene expression on MMC prolif-
eration and ECM accumulation after exposure to highconcentrations of glucose where investigated. This was
carried out in vitro following transfection of MMCs with
a plasmid carrying the Gremlin gene. Cell proliferation
was determined using BrdU ELISA. Cell proliferation
was found to be significantly higher in the NG + P (P <
0.05), HG (P < 0.05) and HG +V (P < 0.05) groups com-
pared with the NG group. Transfection with Gremlin
plasmid into MMCs exposed to HG significantly
Figure 2 (See legend on next page.)
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Figure 2 Effects of expression plasmids on the expression of GFP and Gremlin in MMCs. Transient transfection of MMCs with Gremlin
plasmid (pEGFP-N1-Grem1) and Gremlin siRNA plasmid (pGenesil1.1-shGrem1) induced GFP expression, indicating successful transfection. GFP
expression was observed at 12, 24, and 48 h after transfection. MMCs were transfected with Gremlin plasmid (pEGFP-N1-Grem1), Gremlin siRNA
plasmid (pGenesil1.1-shGrem1), or their corresponding negative control plasmids (pEGFP-N1or pGenesil1.1). They were then incubated with NG
(5.5 mM D-glucose). At 48 h after transfection, total RNA and protein were extracted from the cells for Gremlin mRNA and protein expression.
(A) GFP expression was observed through the comparative analysis of bright-field image and corresponding fluorescent image at 12, 24, and 48
h after Gremlin plasmid transfection (200×). (B) GFP expression was observed through the comparative analysis of bright field images and
corresponding fluorescent images at 12, 24, and 48 h after Gremlin siRNA plasmid transfection (200×). (C) The expression of Gremlin mRNA was
detected by real-time polymerase chain reaction (RT-PCR) analysis at 48 h after Gremlin plasmid transfection. (D) The expression of Gremlin
mRNA was detected using RT-PCR analysis 48 h after Gremlin siRNA plasmid transfection. (E) The expression of Gremlin protein was analyzed
using western blot analysis 48 h after Gremlin plasmid transfection. (F) The expression of Gremlin protein was analyzed using western blot
analysis 48 h after Gremlin siRNA plasmid transfection. NG: MMCs incubated with 5.5 mM D-glucose; NG + P: MMCs transfected with pEGFP-N1-
Grem1 plasmid and incubated with 5.5 mM D-glucose; NG + gremlin si: MMCs transfected with pGenesil1.1-shGrem1 plasmid and incubated with
5.5 mM D-glucose; NG + V: MMCs transfected with pEGFP-N1 or pGenesil1.1 plasmid and incubated with 5.5 mM D-glucose. Values are expressed
as means ± S.E.M. *P < 0.05, **P < 0.01 vs. NG.
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(Figure 3A). MMCs in the NG+ P (P < 0.05), HG (P < 0.05)
and HG+V (P < 0.05) groups showed significantly higher
TGF-β1 protein expression levels compared with the
NG group. Transfection with Gremlin plasmid into MMCs
exposed to HG significantly increased HG-induced overex-
pression of TGF-β1 protein (P < 0.01, vs. HG) (Figure 3B).
MMCs in the NG+ P (P < 0.05), HG (P < 0.05) and HG+V
(P < 0.05) groups showed significantly higher CTGF protein
expression levels compared with the NG group. Transfec-
tion with Gremlin plasmid into MMCs exposed to HG sig-
nificantly increased HG-induced overexpression of CTGF
protein (P < 0.05, vs. HG) (Figure 3C). Significant accumu-
lation of collagen IV in the culture medium was observed
in the NG+ P (P < 0.01, vs. NG), HG (P < 0.01, vs. NG) and
HG+V (P < 0.01, vs. NG) groups. Transfection with Grem-
lin plasmid into MMCs exposed to HG significantly
increased HG-induced accumulation of collagen IV (P <
0.01, vs. HG) (Figure 3D). These findings indicate that
Gremlin can increase MMC proliferation and ECM accu-
mulation after exposure to normal and high levels of
glucose.
Effects of Gremlin inhibition on cell proliferation and ECM
accumulation in MMCs
Cell proliferation was detected using BrdU ELISA. Trans-
fection of the Gremlin siRNA plasmid into MMCs exposed
to NG significantly inhibited cell proliferation (P < 0.05, vs.
NG). Cell proliferation was found to be significantly higher
in the HG (P < 0.05) and HG+V (P < 0.05) groups com-
pared with the NG group. Transfection of the Gremlin
siRNA plasmid into MMCs exposed to HG significantly
inhibited HG-induced cell proliferation (P < 0.05, vs. HG)
(Figure 4A). Transfection with Gremlin siRNA plasmid into
MMCs exposed to NG significantly inhibited expression
of TGF-β1 protein (P < 0.05, vs. NG). MMCs in the HG
(P < 0.05) and HG+V (P < 0.05) groups showed signifi-
cantly higher levels of TGF-β1 protein compared with the
NG group. Transfection with Gremlin siRNA plasmid intoMMCs exposed to HG significantly inhibited HG-induced
overexpression of TGF-β1 protein (P < 0.05, vs. HG)
(Figure 4B). Transfection with Gremlin siRNA plasmid into
MMCs exposed to NG significantly inhibited expression
of CTGF protein (P < 0.01, vs. NG). MMCs in the HG
(P < 0.01) and HG+V (P < 0.01) groups showed signifi-
cantly higher CTGF protein levels compared with the NG
group. Transfection with Gremlin siRNA plasmid into
MMCs exposed to HG significantly inhibited the HG-
induced overexpression of CTGF protein (P < 0.05, vs. HG)
(Figure 4C). Transfection with Gremlin siRNA plasmid into
MMCs exposed to NG significantly inhibited accumulation
of collagen IV (P < 0.01, vs. NG). Significant accumulation
of collagen IV in the culture medium was observed in the
HG (P < 0.01, vs. NG) and HG+V (P < 0.01, vs. NG)
groups. Transfection with Gremlin siRNA plasmid into
MMCs exposed to HG significantly reduced the accumula-
tion of collagen IV (P < 0.01, vs. HG) (Figure 4D). These
findings indicate that inhibition of Gremlin can normalize
MMC proliferation and ECM accumulation after exposure
to high concentrations of glucose, indicating that Gremlin
inhibition may have beneficial effects.
Effect of Gremlin on activation of the ERK1/2 pathway in
MMCs
In order to confirm the effect of glucose exposure on
ERK1/2 pathway activation in MMCs, cells were cultured
in media containing 5.5 mM glucose (NG), prior to stimu-
lation with NG plus 24.5 mM mannitol (M) or 30 mM glu-
cose (HG) for 6, 12, 24 and 48 h. At the end of each time
point, pERK1/2 protein levels were evaluated using western
blot analysis. We found levels of pERK1/2 protein increased
during the first 6 h after HG stimulation (P < 0.05, vs. NG),
peaking at 24 h (P < 0.01, vs. NG) (Figure 5A). In addition,
no differences were found in MMCs cultured under condi-
tions of NG plus mannitol among different time points.
These findings indicate that HG can induce activation of
the ERK1/2 pathway in MMCs. In order to confirm the ef-
fect of Gremlin on activation of ERK1/2 pathway in MMCs,
Figure 3 Effects of Gremlin plasmid on cell proliferation and TGF-β1, CTGF and collagen IV expression in MMCs. MMCs were transfected
with Gremlin (pEGFP-N1-Grem1) or corresponding negative control (pEGFP-N1) plasmids and incubated with HG (30 mM D-glucose) for 24 h.
(A) Cell proliferation was examined using BrdU ELISA. Total (B) TGF-β1 and (C) CTGF proteins levels were determined using western blot analysis.
(D) Culture medium was collected for measurement of collagen IV concentration by radioimmunoassay. NG: MMCs incubated with 5.5 mM
D-glucose; NG +M: MMCs incubated with 5.5 mM D-glucose plus 24.5 mM mannitol; NG + V: MMCs transfected with pEGFP-N1 plasmid and
incubated with 5.5 mM D-glucose; NG + P: MMCs transfected with pEGFP-N1-Grem1 plasmid and incubated with 5.5 mM D-glucose; HG: MMCs
incubated with 30 mM D-glucose; HG + V: MMCs transfected with pEGFP-N1 plasmid and incubated with 30 mM D-glucose; HG + P: MMCs
transfected with pEGFP-N1-Grem1 plasmid and incubated with 30 mM D-glucose. Values are expressed as means ± S.E.M. *P < 0.05,**P < 0.01, vs.
NG, #P < 0.05, ##P < 0.01, vs. HG.
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plasmid and Gremlin siRNA plasmid into MMCs exposed
to NG and HG conditions, after which pERK1/2 protein
levels were assessed by western blot analysis. MMCs in
the NG+ P (P < 0.05), HG (P < 0.05) and HG+V (P < 0.05)
groups showed significantly higher protein levels of
pERK1/2 compared with the NG group. Transfection with
Gremlin plasmid in MMCs exposed to HG significantly
induced HG-induced overexpression of pERK1/2 (P < 0.01,
vs. HG) (Figure 5B). Transfection with Gremlin siRNA
plasmid in MMCs exposed to NG significantly inhibited
expression of pERK1/2 (P < 0.01 vs. NG). MMCs in the HG(P < 0.01) and HG+V (P < 0.01) groups showed signifi-
cantly higher protein levels of pERK1/2 compared with the
NG group. Transfection with Gremlin siRNA plasmid in
MMCs exposed to HG significantly inhibited the HG-
induced overexpression of pERK1/2 (P < 0.01, vs. HG)
(Figure 5C). These findings indicate that Gremlin can in-
duce activation of the ERK1/2 pathway in MMCs.
Discussion
In the present study, we found that HG up-regulates the
expression of Gremlin in MMCs and that Gremlin
induces cell proliferation and accumulation of ECM in
Figure 4 Effects of Gremlin siRNA plasmid on cell proliferation and TGF-β1, CTGF and collagen IV expression in MMCs. MMCs were
transfected with Gremlin siRNA (pGenesil1.1-shGrem1) or corresponding negative control (pGenesil1.1) plasmids, and incubated with HG (30 mM
D-glucose) for 24 h. (A) Cell proliferation was examined using BrdU ELISA. Total (B) TGF-β1 and (C) CTGF protein levels were determined using
western blot analysis. (D) Culture medium was collected for measurement of collagen IV concentration by radioimmunoassay. NG: MMCs
incubated with 5.5 mM D-glucose; NG +M: MMCs incubated with 5.5 mM D-glucose plus 24.5 mM mannitol; NG + V: MMCs transfected with
pGenesil1.1 plasmid and incubated with 5.5 mM D-glucose; NG + gremlin si: MMCs transfected with pGenesil1.1-shGrem1 plasmid and incubated
with 5.5 mM D-glucose; HG: MMCs incubated with 30 mM D-glucose; HG + V: MMCs transfected with pGenesil1.1 plasmid and incubated with 30
mM D-glucose; HG + gremlin si: MMCs transfected with pGenesil1.1-shGrem1 plasmid and incubated with 30 mM D-glucose. Values are expressed
as means ± S.E.M. *P < 0.05, **P < 0.01, vs. NG, #P < 0.05, ##P < 0.01, vs. HG.
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showing that Gremlin enhances the ERK1/2 pathway ac-
tivation in MMCs.
Increased expression of Gremlin was recently detected
in experimental models of DN [7]. Gremlin was first
named as Induced in High Glucose 2 (IHG-2) in mesan-
gial cells exposed to high extracellular glucose in vitro.
Subsequent in silico cloning revealed IHG-2 to be
human Gremlin [7,12]. Increased Gremlin expression
has also been demonstrated in human mesangial cellsexposed to cyclic mechanical strain in vitro and in both
streptozotocin-induced DN and the 5/6 nephrectomy
model of glomerular hypertension in vivo [7]. In this
study, we show HG time dependently up-regulates mRNA
and protein levels of Gremlin in MMCs, suggesting that
Gremlin expression is induced by HG.
Recent in vitro and in vivo evidence suggests that Grem-
lin participates in DN [13]. Human DN is associated with
significantly increased Gremlin expression relative to nor-
mal or minimally changed kidneys; Gremlin expression
Figure 5 Effects of Gremlin on pERK1/2 protein expression in MMCs. MMCs were cultured in NG then stimulated (M) or HG for 6, 12, 24,
and 48 h. At the end of each time point, total cell protein contents were extracted for assessment of pERK1/2 protein expression. MMCs were
transfected with Gremlin (pEGFP-N1-Grem1), Gremlin siRNA (pGenesil1.1-shGrem1) or their corresponding negative control (pEGFP-N1 or
pGenesil1.1, respectively) plasmids, and incubated with HG for 24 h. Protein was then extracted from the cells for evaluation of pERK1/2 protein
expression. (A) The level of pERK1/2 protein expression was assessed using western blot analysis in MMCs incubated with HG for the indicated
times (0–48 h). Values are expressed as means ± S.E.M. *P < 0.05, **P < 0.01 vs. NG. (B) MMCs were transfected with Gremlin or the corresponding
negative control plasmids and the expression of pERK1/2 protein was assessed by western blot analysis 24 h after HG stimulation. (C) MMCs were
transfected with Gremlin siRNA or the corresponding negative control plasmids and the expression of pERK1/2 protein was assessed using
western blot analysis 24 h after HG stimulation. NG: MMCs incubated with 5.5 mM D-glucose; NG + M: MMCs incubated with 5.5 mM D-glucose
plus 24.5 mM mannitol; NG + V: MMCs transfected with pEGFP-N1/pGenesil1.1 plasmids and incubated with 5.5 mM D-glucose; NG + P: MMCs
transfected with pEGFP-N1-Grem1 plasmid and incubated with 5.5 mM D-glucose; NG + gremlin si: MMCs transfected with pGenesil1.1-shGrem1
plasmid and incubated with 5.5 mM D-glucose; HG: MMCs incubated with 30 mM D-glucose; HG + V: MMCs transfected with pEGFP-N1/
pGenesil1.1 plasmids and incubated with 30 mM D-glucose; HG + P: MMCs transfected with pEGFP-N1-Grem1 plasmid and incubated with 30
mM D-glucose; HG + gremlin si: MMCs transfected with pGenesil1.1-shGrem1 plasmid and incubated with 30 mM D-glucose. Values are expressed
as means ± S.E.M. *P < 0.05,**P < 0.01, vs. NG, #P < 0.05,##P < 0.01, vs. HG.
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fibrosis [6]. The co-localization of Gremlin and TGF-β1
expression in glomeruli and tubular cells suggests that
Gremlin may be important to mediating some of the
pathological effects of TGF-β1 [14]. TGF-β, when added
to serum-restricted human mesangial cells, has been
found to augment Gremlin expression, but the stimulatory
effect of high glucose on Gremlin expression was attenu-
ated by the addition of anti-TGF-β antibody [7]. This sug-
gests that Gremlin is induced by TGF-β under diabetic
conditions. Certain Gremlin gene variants are associated
with DN, and Gremlin is implicated in the pathogenesis of
DN [15]. These data suggest a pathogenetic role for
Gremlin in DN and identify Gremlin as a potential thera-
peutic target. Accumulating amounts of evidence suggest
that cell proliferation and ECM synthesis, which are char-
acteristics of mesangial cell activation, occur in DN and
cause interstitial fibrosis [16,17]. Early renal hypertrophy,
which results partially from cell proliferation, acts as a
pacemaker for subsequent irreversible structural changes,
such as glomerulosclerosis and tubulointerstitial fibrosis
[18]. Second, the fibrotic cytokines TGF-β1 and CTGF are
important to the glomerular accumulation of ECM and
can induce persistent fibrosis [19-21]. Blockage of these
cytokines has shown some promise in human diabetic kid-
ney disease [22]. We successfully constructed a recombin-
ant expression plasmid of Gremlin, pEGFP-N1-Grem1,
performed an experiment in which MMCs overexpressed
Gremlin RNA, and evaluated its effects on cell proliferation
and ECM accumulation under high-glucose conditions.
Our results demonstrated that transfection with Gremlin
plasmid to MMCs exposed to high levels of glucose
increased cell proliferation and induced expression of TGF-
β1, CTGF, and collagen IV, indicating that Gremlin plays a
significant role in cell proliferation and ECM accumulation.
Gremlin expression is enhanced in mesangial cells cul-
tured under high-glucose conditions, and inhibition of
Gremlin exerts beneficial effects on the diabetic kidney.
Zhang et al [23] showed that inhibition of Gremlin exerted
beneficial effects on the diabetic kidney mainly through
maintenance of BMP-7 activity. In a streptozotocin-
induced model of type 1 diabetes, knockout mice hetero-
zygous for Grem1 gene deletion (Grem1+/-) exhibit pro-
tection from the progression of diabetic kidney disease
[24]. Inhibition of Gremlin expression has been shown to
block TGF-β-induced ECM accumulation [25,26]. RNAi,
also known as RNA interference, is a powerful tool for si-
lencing gene expression. Short interfering 21–23-mer
double-stranded RNA segments (siRNA) guide mRNA
degradation in a sequence-specific fashion [27]. Unlike
other types of RNAi, such as RNAi molecular synthesis in
vitro or the construction of expression frames, shRNA can
be used to construct RNAi DNA template expression vec-
tors directly in vitro, and it is more stable. shRNA inmammal cells not only blocks the expression of target
genes but it is also stably passed on to subsequent genera-
tions. It has replaced traditional gene knockout techniques
in the establishment of transgenic cell lines and transgenic
animals. For these reasons, the construction of shRNA ex-
pression vectors has become the most commonly used
RNAi technique. We successfully constructed recombin-
ant expression plasmid for Gremlin and pGenesil1.1-
shGrem1, performed an experiment involving RNA inter-
ference inhibition of the overexpression of Gremlin by
transfection of eukaryotic expression vector in MMCs
under high-glucose conditions. The results showed that
the presence of the Gremlin siRNA plasmid reversed
high-glucose induced abnormalities, including increased
cell proliferation and induced expression of TGF-β1,
CTGF, and collagen IV in MMCs exposed to high levels of
glucose, indicating beneficial effects of Gremlin inhibition.
Little is known about the relationship between Gremlin
and the activation of the ERK1/2 signal pathway. ERK1/2 is
known as an important kinase in the intracellular signal
transduction system leading to cell proliferation and pro-
tein synthesis [28]. The ERK1/2 pathway is activated in dia-
betic glomeruli or glomerular mesangial cells cultured
under high-glucose conditions and it may contribute to the
development of DN [29]. The activation of the ERK1/2
pathway is a requirement for the hyperglycemia-induced
production of TGF-β1 and CTGF in MMCs [30]. In this
way, the ERK pathway plays a key role in DN. High con-
centrations of glucose were also associated with increased
levels of Gremlin mRNA in bovine retinal pericytes; Grem-
lin expression was modulated by inhibition of ERK1/2 acti-
vation, suggesting that Gremlin may play a role in the
regulation of the ERK1/2 pathway [31]. Stabile et al [32]
reported that Gremlin up-regulated pERK1/2 expression in
subcutaneous microvascular endothelial cells ( SIE ) stimu-
lated by recombinant murine Drm/ Gremlin (rDrm) (50
ng/ml) for 0–2012;60 min. pERK1/2 is a marker of ERK1/2
signal pathway activation. Based upon our data, we con-
cluded that high levels of glucose induced the activation of
the ERK1/2 pathway in the MMCs. These are the first find-
ings that show that the transfection with Gremlin plasmid
can significantly up-regulate HG-induced overexpression
of pERK1/2 in MMCs, and Gremlin siRNA plasmid
reversed this abnormality, suggesting that Gremlin induced
the activation of the ERK1/2 pathway.
The issue of whether Gremlin has BMP-independent
effects on the pathogenesis of DN must be addressed. A
number of studies have reported that Gremlin can interact
directly with cell surface proteins, such as Slit protein
family members or cell-surface heparan-sulfate proteogly-
cans, to alter cell function, indicating a mechanism of ac-
tion for Gremlin that is independent of BMP antagonism.
Chen et al [33] identified Slit1 and Slit2 as Gremlin-inter-
acting proteins. BMP2 or BMP4 did not interfere with the
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Gremlin protein responsible for BMP-binding is distinct
from that interacting with Slit proteins. In a second study,
Stabile et al [32] showed that Gremlin binds with high af-
finity to the surface of subcutaneous microvascular endo-
thelial cells via uncharacterized cell-surface heparan-
sulfate proteoglycans (HS-PGs). Molar excess of BMP4
did not hinder Gremlin-proteoglycan binding, again sug-
gesting that different sites on the Gremlin protein, other
than those binding BMPs, are involved. Furthermore,
Gremlin proteoglycan binding was shown to cause tyro-
sine phosphorylation of ERK1/2 in these systemic endo-
thelial cells. HS-PG is the main component of the
glomerular capillary basement membrane, mesangial cell
and vascular wall, and plays an important role in mainten-
ance of their structural integrity. Our study shows that
Gremlin induces ERK1/2 pathway activation in mesangial
cells cultured under high glucose exposure, which indicates
that Gremlin might interact directly with mesangial
cell surface HS-PGs to alter cell function through BMP-in-
dependent pathways. Gremlin was also found to bind
VEGF receptor-2 (VEGFR2), the main transducer of
VEGF-mediated angiogenic signals, in a BMP-independent
manner. In this way, Gremlin represents a novel proangio-
genic VEGFR2 agonist, distinct from VEGF family ligands.
It has implications in vascular development, angiogenesis-
dependent diseases and tumor neovascularization [34].
Gremlin was also found to be overexpressed in various
human tumors including carcinomas of the cervix, endo-
metrium, lung, ovary, kidney, breast, colon and pancreas
[35,36]. It was recently reported that Gremlin induces
BMP-independent tumor cell proliferation, migration and
invasion [37]. The ability of Gremlin to regulate cell
growth via a BMP-independent pathway in DN merits fur-
ther study.
Conclusion
In conclusion, we observed that HG up-regulates the ex-
pression of Gremlin in vitro. Gremlin in turn induces
cell proliferation and accumulation of ECM in MMCs.
This is the first piece of evidence to show that Gremlin
enhances the ERK1/2 pathway activation in MMCs.
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